Skip to content

Company information lookup

IMUGENE LIMITED (IMU)

An Australian immuno-oncology focused biopharmaceutical company developing HER2 +ve gastric and breast cancer vaccines. The Companys lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER-2/neu.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
IMU 0.017 0% 0.016 0.017 0.017 0.017 0.017 1,288,941

IMUGENE LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code IMU
Securities
Official Listing Date 24 November, 1993
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.imugene.com
Registered Office Address Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3142
Head Office Telephone 03 9824 5254
Head Office Fax 03 9822 7735
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Paul Hopper (Executive Chairman, Non Exec. Director)
Dr Nicholas Ede (Executive Director)
Mr Otto Buttula (Non Exec. Director)
Dr Axel Hoos (Non Exec. Director)
Mr Phillip Hains (CFO)
Company Secretary Mr Justyn Stedwell
Mr Phillip Hains (Joint Co. Secretary)
Principal Activities An Australian immuno-oncology focused biopharmaceutical company developing HER2 +ve gastric and breast cancer vaccines. The Companys lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER-2/neu.

IMUGENE LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
29/07/2014 asterix HER-Vaxx patent application receives US Notice of Allowance 1 PDF
25/07/2014 asterix Appendix 4C - quarterly 5 PDF
16/07/2014 asterix Mymetics Engaged to Manufacture HER-Vaxx 2 PDF
08/07/2014   Initial Director's Interest Notice 2 PDF
07/07/2014   Otto Buttula appointed Non-Executive Director 2 PDF
11/06/2014   Investor Update 4 PDF
27/05/2014 asterix Imugene Commences Manufacture of its Gastric Cancer Vaccine 2 PDF
05/05/2014   Change in substantial holding 2 PDF
23/04/2014 asterix Appendix 4C - quarterly 5 PDF
23/04/2014   Gastric cancer specialist joins Imugene SAB 1 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
22 Aug 2014 0.017 0% 0.017 0.017 1,288,941
20 Aug 2014 0.017 0% 0.017 0.017 1,273,706
19 Aug 2014 0.017 0% 0.017 0.017 2,174,214
18 Aug 2014 0.017 6.25% 0.017 0.017 2,005,000
15 Aug 2014 0.016 0% 0.017 0.016 1,124,109

* Volume of shares shown represents only those shares traded on ASX.

IMUGENE LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security IMU. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security IMU

Warrants & Structured Products

No warrants & Structured Products are available over the security IMU

ASX CFDs

No Contracts For Differences are available over the security IMU